These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 8841603

  • 1. IP3 receptor-ligand. 2: Synthesis and molecular mechanics calculation of adenophostin A.
    Hotoda H, Takahashi M, Tanzawa K, Takahashi S, Miyamoto S, Kaneko M.
    Nucleic Acids Symp Ser; 1995; (34):163-4. PubMed ID: 8841603
    [Abstract] [Full Text] [Related]

  • 2. Molecular recognition of adenophostin, a very potent Ca2+ inducer, at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Hotoda H, Murayama K, Miyamoto S, Iwata Y, Takahashi M, Kawase Y, Tanzawa K, Kaneko M.
    Biochemistry; 1999 Jul 20; 38(29):9234-41. PubMed ID: 10413497
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of adenophostin A analogues conjugating an aromatic group at the 5'-position as potent IP3 receptor ligands.
    Mochizuki T, Kondo Y, Abe H, Tovey SC, Dedos SG, Taylor CW, Paul M, Potter BV, Matsuda A, Shuto S.
    J Med Chem; 2006 Sep 21; 49(19):5750-8. PubMed ID: 16970399
    [Abstract] [Full Text] [Related]

  • 4. Conformational analysis of cyclophostin and designed analogs in comparison with the potent IP3 receptor agonist adenophostin A.
    Iwata Y, de Kort M, Challiss RA, van der Marel GA, van Boom JH, Miyamoto S.
    Drug Des Discov; 2001 Sep 21; 17(3):253-63. PubMed ID: 11469755
    [Abstract] [Full Text] [Related]

  • 5. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors.
    Marchant JS, Beecroft MD, Riley AM, Jenkins DJ, Marwood RD, Taylor CW, Potter BV.
    Biochemistry; 1997 Oct 21; 36(42):12780-90. PubMed ID: 9335535
    [Abstract] [Full Text] [Related]

  • 6. A systematic study of C-glucoside trisphosphates as myo-inositol trisphosphate receptor ligands. Synthesis of beta-C-glucoside trisphosphates based on the conformational restriction strategy.
    Terauchi M, Abe H, Tovey SC, Dedos SG, Taylor CW, Paul M, Trusselle M, Potter BV, Matsuda A, Shuto S.
    J Med Chem; 2006 Mar 23; 49(6):1900-9. PubMed ID: 16539376
    [Abstract] [Full Text] [Related]

  • 7. Adenophostin A and analogues modified at the adenine moiety: synthesis, conformational analysis and biological activity.
    Borissow CN, Black SJ, Paul M, Tovey SC, Dedos SG, Taylor CW, Potter BV.
    Org Biomol Chem; 2005 Jan 21; 3(2):245-52. PubMed ID: 15632966
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Liu C, Davis RJ, Nahorski SR, Ballereau S, Spiess B, Potter BV.
    J Med Chem; 1999 Jun 03; 42(11):1991-8. PubMed ID: 10354407
    [Abstract] [Full Text] [Related]

  • 9. Rapid activation and partial inactivation of inositol trisphosphate receptors by adenophostin A.
    Adkins CE, Wissing F, Potter BV, Taylor CW.
    Biochem J; 2000 Dec 15; 352 Pt 3(Pt 3):929-33. PubMed ID: 11104705
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of glucopyranoside-based ligands for D-myo-inositol 1,4,5-trisphosphate receptors.
    Riley AM, Jenkins DJ, Marwood RD, Potter BV.
    Carbohydr Res; 2002 Jun 12; 337(12):1067-82. PubMed ID: 12062522
    [Abstract] [Full Text] [Related]

  • 11. Contribution of the adenine base to the activity of adenophostin A investigated using a base replacement strategy.
    Marwood RD, Jenkins DJ, Correa V, Taylor CW, Potter BV.
    J Med Chem; 2000 Nov 02; 43(22):4278-87. PubMed ID: 11063623
    [Abstract] [Full Text] [Related]

  • 12. Determinants of adenophostin A binding to inositol trisphosphate receptors.
    Morris SA, Nerou EP, Riley AM, Potter BV, Taylor CW.
    Biochem J; 2002 Oct 01; 367(Pt 1):113-20. PubMed ID: 12088506
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interaction.
    Rosenberg HJ, Riley AM, Laude AJ, Taylor CW, Potter BV.
    J Med Chem; 2003 Nov 06; 46(23):4860-71. PubMed ID: 14584937
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological activity of adenophostin derivatives as IP3 receptor ligands.
    Shuto S, Mochizuki T, Abe H, Kondo Y, Matsuda A.
    Nucleic Acids Res Suppl; 2002 Nov 06; (2):23-4. PubMed ID: 12903086
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of potent agonists of the D-myo-inositol 1,4, 5-trisphosphate receptor based on clustered disaccharide polyphosphate analogues of adenophostin A.
    de Kort M, Correa V, Valentijn AR, van der Marel GA, Potter BV, Taylor CW, van Boom JH.
    J Med Chem; 2000 Aug 24; 43(17):3295-303. PubMed ID: 10966748
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor.
    Moris MA, Caron AZ, Guillemette G, Rognan D, Schmitt M, Schlewer G.
    J Med Chem; 2005 Feb 24; 48(4):1251-5. PubMed ID: 15715492
    [Abstract] [Full Text] [Related]

  • 17. Fertilization and inositol 1,4,5-trisphosphate (IP3)-induced calcium release in type-1 inositol 1,4,5-trisphosphate receptor down-regulated bovine eggs.
    Malcuit C, Knott JG, He C, Wainwright T, Parys JB, Robl JM, Fissore RA.
    Biol Reprod; 2005 Jul 24; 73(1):2-13. PubMed ID: 15744020
    [Abstract] [Full Text] [Related]

  • 18. Adenophostin-medicated quantal Ca2+ release in the purified and reconstituted inositol 1,4,5-trisphosphate receptor type 1.
    Hirota J, Michikawa T, Miyawaki A, Takahashi M, Tanzawa K, Okura I, Furuichi T, Mikoshiba K.
    FEBS Lett; 1995 Jul 17; 368(2):248-52. PubMed ID: 7628615
    [Abstract] [Full Text] [Related]

  • 19. Ca2+ and calmodulin differentially modulate myo-inositol 1,4, 5-trisphosphate (IP3)-binding to the recombinant ligand-binding domains of the various IP3 receptor isoforms.
    Vanlingen S, Sipma H, De Smet P, Callewaert G, Missiaen L, De Smedt H, Parys JB.
    Biochem J; 2000 Mar 01; 346 Pt 2(Pt 2):275-80. PubMed ID: 10677344
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of the C-glycosidic analogue of adenophostin A and its uracil congener as potential IP(3) receptor ligands. Stereoselective construction of the C-glycosidic structure by a temporary silicon-tethered radical coupling reaction.
    Abe H, Shuto S, Matsuda A.
    J Org Chem; 2000 Jul 14; 65(14):4315-25. PubMed ID: 10891132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.